|
ST. LOUIS (AP) - Saint Louis University said Monday it will lead a national study of a new vaccine for smallpox, once one of the world's most feared diseases and now considered a threat to re-emerge as a bioweapon.
The university's Center for Vaccine Development and six other U.S. centers will examine how quickly the test vaccine stimulates an immune response and whether it would be as effective as a vaccine used in previous global smallpox eradication efforts.
The study is sponsored by the National Institutes of Health and the test vaccine's Danish manufacturer, Bavarian Nordic.
|